ðä¿¡è ã®å人ãž
çããã¯ïŒãã€é ïŒäœããã£ããã«ä»ã®çã£ãäžçã«æ°ä»ããŸããã?
å
æ¥ïŒðä¿¡è
ã®å人ããã£ãšäœèª¿ãããããªããšèšãã®ã§ãããã¯ã¹ãå§ãïŒããã€ãã®é¢é£ãµã€ãã玹ä»ãããšããïŒ
ãå»è
ã§ããªãã®ã«ïŒäœæ
ïŒã³ããðãã€ãããšãããã®ã?ãããæ¬åœãªãïŒãã€ããããã£ãŠãã®ã?ã
ãšåãè©°ããããŸããã
ä»æŽãã!ã£ãŠæãã§ããïŒ2021幎ãããðæã€æ°ãªãïŒãã¬ããéµåã¿ã«ããïŒã¡ãããšèª¿ã¹ãããç¹ã«åäŸã®æ¥çš®ã¯ãããšå¿ åããŠãããïŒåœãåå ãæ確ã«ããªãè¶
éæ»äº¡ã»éå°æ»ãç¶ããŠããããšãïŒããšããããšã«è©±ããŠããŸãããïŒåœŒã®è³ã«ã¯å
¥ã£ãŠããªãã£ãããã§ãã
ãããã¯ã€ãã·ã§ãŒã°ããèŠãŠããïŒðã®åŸã«äœèª¿æªããªã£ãŠãðã埮塵ãçããŸãããã
ãããã§èª¿ã¹ããå±±ã»ã©èšŒæ ãåºãŠãããã ããïŒãŸãã¯èªåã§èª¿ã¹ãããã§ïŒèªåã®é ã§èãããã
ãšæãã€ã€ãïŒé·å¹Žã®å人ãªã®ã§ãæåããèšã£ãŠããããšã
ãŸã2020幎ååïŒææè
ã100人/æ¥ã®æµè¡ãç
ã«å¯ŸãïŒå
šã¡ãã£ã¢ïŒå
šäžçãæããŠïŒèªç²ããã¹ã¯ã匷èŠããããšã«ç°åžžãæããªãã£ãã®ã?
2019幎以åã®å¬ã«ã¯æ¯é±ã€ã³ãã«ææè
äœåäžäººã ã£ãã®ã«å€§éšãããŠãªãã£ãã®ã«ã
ããã§ã埡çšã¡ãã£ã¢ã¯ããã£ãŠææãç
œãäžçäžã®æ¿åºãããã¯ããŠã³åŒ·è¡ã
èªç²èŠè«ã«ã¯æ³çææåãç¡ãã®ã«ïŒå調å§åã«å±ãçŽ çŽã«åŸãæ¥æ¬äººã
ãã®å³ãèŠãŠïŒ2020幎æç¹ã§æ¬æ°ã§èªç²ããã¹ã¯ãå¿ èŠã ã£ããš?
ãã®ãšãæ¬åœã«èªç²ãå¿
èŠã ã£ããªãïŒææã»æ»è
çå¢ã®2022幎以éããèªç²ãããªã?ãŸããŠãâ
€é¡ç§»è¡ãªããŠæãåŸãªãã¯ãã
ãææã®ææçããšç
œã£ãã¡ãã£ã¢ãæ¿åºã«ä¹ããããã ãã§ããã
è«ççæèãåæ¢ããŠïŒãããŸã§äžåºŠãèããããšãªããç¡çç¶ææããªããŠã®ãçã«åãïŒçºçããŠãªãã®ã«PCRè©æ¬ºæ€æ»ã®åŒ·å¶ã«çåãæ±ããïŒçã®éããªãåœä»€ã«ãåŸé ã«åŸãïŒããã«åããè
ã培åºçã«å©ãã
ãããŠïŒäžççææã確èªããããšã»ãŒåæã«ïŒäžçäžã§å£ãæããŠãæ©æ¥ãªã¯ã¯ãã³éçºãããã¯ã¯ãã³ãããæäžäž»ããã¯ã¯ãã³æãŠã°å
ã®äžçã«ãã£ãŠèšã£ãŠãããšã®ç°åžžãã
æŽå²ãåŠã°ãªãããïŒææã«é¥ãïŒäžå®ãç
œãïŒææžçã瀺ãïŒããããå©ããéã¯ç¡ããšä¿¡ã蟌ãŸãããšãã"圌ã"ã®åžžå¥æ段ã«ïŒäœåºŠãåŒã£æãã£ã人ã
ã
äžåœå
񇜆
ãã³ãããšèªããã®ã2020幎1æ23æ¥ã
WHOããã³ãããã¯å®£èšãåºããã®ã3æã
ãããã10ã«æãçµããªã2020幎æ«ã«ã¯ã€ã¹ã©ãšã«ãç±³è±ã§æ¥çš®éå§ã
ããããããïŒäžçåã®mRNAéºäŒåðã§ãã?
ðã¯ã¯ã®æ¹ã
ã¯ïŒmRNAã¯30幎以äžç 究ãããŠããã®ã§ãã£ãŠïŒ10ã«æã§äœã£ããããããªããšèšãèš³ããŠãŸãããïŒãã±ããã¯äœå幎ãç 究ãç¶ããŠãŠãæã¡äžãã«å€±æããŠãŸããã©?
2æéã§èšèšãïŒ2ã«æã§è£œé ãïŒ6ã«æããè©ŠéšããŠããªãäžçåã®ãã±ããã«ãç 究ã¯äœå幎ããã£ãŠãŸãããå®å
šã§ãããšèšãããŠä¹ããŸã?
ãã±ããã®é£è¡ã¯ç©ççŸè±¡ã§ãããïŒã©ã®ãããªããšãèµ·ããåŸãããæ³å®ããŠèšèšã»è£œé ãããŸããããã§ãäºæããªãäºæ ãçºçãïŒå£ãããïŒææªïŒå¢èœãããŸãã
ã§ã¯ïŒäººäœã¯ãããç©ççŸè±¡ãããåçŽãªã®ã§ãããã?
æ³å®å€ã®ããšã¯èµ·ãããªãã®ã§ãããã?
äžæ²»ã®ç
ããŸã ãŸã ããïŒ10æ³ãŸã§çããããªãåäŸãã¡ãå±±ã»ã©ããã®ã«ã
人皮ãåœã§çºçããçŸç
ãéç床ãç°ãªãã®ã«ã
2019幎ãŸã§ã¯æ¥æ¬ã ãã§ãã€ã³ãã«ãšã³ã¶ã®ææè
ãæ¯å¹Ž3000äžäººïŒäº¡ããªã人ã3000人ãããã«ããããããå¹æçãªã¯ã¯ãã³äœããªãã£ãã®ã«ã
ããã«ïŒéºäŒåæäœããè¬ãé£ã¹ç©ãå°æ¥çã«äººäœã«ã©ããªåœ±é¿ãäžããã®ãïŒèª°ãããããªãã®ã«ã
äŸãïŒèŽæ»ç20%è¶
ã®æ¬ç©ã®ææã®ææçã§ãã£ãŠãïŒå¹æãåãããïŒå°æ¥äœãèµ·ãããåãããªããã®ãïŒææããŠãªãå¥åº·ãªæã«æã€ãã©ããæ©ã¿æã§ããã
ãŸããŠãïŒ
ã»COVID-19 çºçäºé²å¹æã«ã€ããŠã¯è©äŸ¡ãããŠããªã
ã»æ¬å€ã®COVID-19 ã®éçåæå¶å¹æã¯ç¢ºèªã§ããŠããªã
ã»æ¬å€æ¥çš®åŸé·æã®ååãªå®å
šæ§ããŒã¿ã¯åŸãããŠããªã
ã»æ¬å€ã®ããã§ã®çŸæ£å¢åŒ·ãªã¹ã¯ã¯äžæã§ãã
ãªã©ãšåçœããŠããðã®ç¹äŸæ¿èªå ±åæžãèªãã ããªãããã§ãã
ææç ã¯ã颚éªããšèšã£ãŠãŠäœå人ãã®ææè
ãããããã§ãããïŒã¯ã¯ãã³ãšäžŠè¡ããŠïŒæ¢åã®é¢šéªè¬ãšãã€ãã«ã¡ã¯ãã³ãšãããããã·ã¯ãããã³ãšãã®å¹æã«ã€ããŠäžçäžã®å»çæ©é¢ã§åãçµãã°ããã®ã«ïŒäžçåã®éºäŒåã¯ã¯ãã³ã ããäžçãææžããå¯äžã®æ¹æ³ã§ããïŒäžçäžã§äœå人ãåŠæ¹ãããŠãã€ãã«ã¡ã¯ãã³ãšèšãã ãã§BANã
ãããç°åžžã ãšæããªãæç¹ã§çµäºã§ãã
ãããã§ïŒå»¶ã¹ïŒååè¶ ãæåããŠããŸãïŒãã®çµæïŒðæ¥çš®åæ°ãšã³ããéœæ§è æ°ã人å£åæ çµ±èšã®æ»è æ°ã䞊ã¹ããšïŒæ¥çš®ãããææççºãèµ·ããè¶ éæ»äº¡ãå¢å ããããšã¯æçœã
2011幎ããã®æ»è
æ°ã®å€åãèŠããšïŒ2022幎以éæ¿å¢ããŠããã®ã«ã¡ãã£ã¢ã¯èŠã¬ãµãïŒæ¿åºã¯èª¿æ»ããããªãã
(å®éã¯åæã調æ»ãããŠããåå ãããã£ãŠããã©èšããªãã ãã§ãã)
ãšãã話ããã£ãšããŠããã«ããããããïŒéæ¥çš®è
ã¯éåœæ°ã ïŒãã¹ã¯ããªã奎ã¯ç¯çœªè
ã ïŒðãå±éºèŠããé°è¬è«è
ãïŒãšæŽèšãåãäžåèãè³ãæããªãã£ãã®ã¯ããªãæ¹ã§ãã?
ããã§ãæ¥æ¬ãäœãšãããªããã°ãšèŠåãåºãç¶ããã®ã«ïŒãããä»æŽïŒãæåããåãã£ãŠããªãäœæ
èšããªãã£ããã !ãã£ãŠã»ã»ã»ðã®å¯äœçšã®äžã€ã«èšæ¶é害ã£ãŠã®ãããã®ããã
ä¿¡çšãçºä¿¡åããªãç§ã§ããïŒç§ã®è©±ãèããŠïŒèªåã§èª¿ã¹ãŠ1床ãæãããã¹ã¯ãããŠãªã人ãããŸãã2床ðæ¥çš®åŸã«ç§ã®è©±ãæ¬åœãããšæ°ä»ããŠïŒãã®åŸã¯äžåºŠãæã£ãŠãªã人ãããããããŸãã
ãªã®ã§ïŒä»æ¥ãŸã§ç§ã®èšèãè³ã«å
¥ããªãã£ãã®ã¯ãæ®å¿µã§ãããããšããèšãããããããŸããã
åæã"圌ã"ã®ç®çã®äžã€ãªã®ã§ïŒä»æŽæ¬åœã®ããšãèšã£ãŠäžå®ãç
œãïŒé¢ä¿æ§ãæªãããŠåæãæãããïŒäœãèšãããã®ãŸãŸæ¿åºãšã¡ãã£ã¢ãä¿¡ããŠæ°žé ã«ããç¶ããŠãããã»ããããããªïŒãšãæã£ãã®ã§ããã»ã»ã»
ç¯çœªãèŠãŠèŠã¬æ¯ããããå
±ç¯ã§ããïŒç®ã®åã§åœãèœãšã人ã
ãæŸã£ãŠããããã«ã¯ãããŸããããïŒåæãèµ·ããã¬ããèŠåãç¶ç¶ããŠãããŸãã
èªåã家æã被害ã«éããªããšè¶
éæ»äº¡ãðåŸéºçãä»äººäºã§ïŒãŸãã§æããããªã©ã©ããã«å¿ããŠããããã§ãã(ã§ããæãããã¯ã¯ãã³ãã£ãŠèšèã«éšããããã ããªã)
ãããïŒå¿ããŠãããªãæ ¹æ°åŒ·ãäœåºŠã§ãæãåºãããŠãããŸãããã
ãŸãã¯ïŒã¡ãã£ã¢ã¯çå®ãäŒããªããšããäºå®ãåºæ¬ã«ïŒç€ŸäŒã®åããèŠãŠïŒèªåã§èª¿ã¹ïŒèªåã§èããç¿æ £ãã€ããªããšïŒå®¶æããå®ããªãæ代ã ãšç¥ããšããããã§ããã
ãããïŒé ã¬ãã¬ãã®ðä¿¡è ã®å人ããããªããšãèšãåºããã®ã§ãããïŒãªã»ãã®ç€é¢ãäžæ°ã«é»ããçã£çœã«å€ããã¿ã€ãã³ã°ãè¿ã¥ããŠããã®ããªããšïŒæããæªæ¥ã«æåŸ ããŠããä»æ¥ãã®é ã§ãã